Cbre 2025 Life Sciences Outlook. U.S. Life Sciences Outlook 2025 CBRE Various drivers of life sciences industry expansion appear well entrenched, acting as a. Life Sciences Outlook highlights continued growth driven by key factors such as an improving economy, robust sector employment, and a more favorable capital market environment
Supply & Demand Trends CBRE from www.cbre.com
economy, improving capital markets and growing life sciences employment are supporting momentum in several lab/R&D real estate indicators Lab/R&D leasing activity trended higher in 2024 (e.g., a 41% year-over-year increase in Q3) and demand should continue to improve in 2025..
Supply & Demand Trends CBRE
Previous cycles show that any slowdown in life sciences employment likely won't be as severe as that of the broader economy Previous cycles show that any slowdown in life sciences employment likely won't be as severe as that of the broader economy Life Sciences Outlook highlights continued growth driven by key factors such as an improving economy, robust sector employment, and a more favorable capital market environment
Supply & Demand Trends CBRE. On the other hand, global venture capital increased (as did mergers and acquisitions), U.S Life Sciences Outlook provides investors and occupiers alike with valuable insights to where the market is headed this year.
News Release CBRE 2024 US Life Sciences Outlook Wave of LabConstruction Completions Will. Life sciences lab and R&D property sales dropped to their lowest level in more than a decade in 2024, primarily due to high interest rates and weak supply-and-demand fundamentals, according to CBRE With more than 140,000 professionals (including Turner & Townsend employees) in over 100 countries, CBRE is the global leader in commercial real estate services and investment.